Prostate cancer (advanced, hormone dependent) - degarelix depot: evaluation report

Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.

Prostate cancer (advanced, hormone dependent) - degarelix depot: evaluation report

01 - Pre-Meeting Briefing prepared by NICE

02 - Submission from the technology manufacturer – Ferring Pharmaceuticals 

03 - NICE request to the manufacturer for clarification on their submission

04 - Manufacturer clarification response 

05 - Manufacturer clarification response – Updated Results

05 - Manufacturer clarification response – Updated Results Until Death

07 - Consultee submission – British Association of Urological Surgeons

08 - Consultee submission – British Uro-Oncology Group 

09 - Consultee submission – Prostate Cancer Support Federation 

10 - Consultee submission – Prostate Cancer UK 

10 - Consultee submission – Royal College of Physicians 

11 – Patient expert personal perspective – Baxter –Smith

12 – Clinical expert personal perspective – Heather Payne  

13 – Clinical expert personal perspective – Isabel Syndikus 

13 – Patient expert personal perspective – Stuart Watson 

14 - Evidence Review Group report prepared by School of Health and Related Research (ScHARR) 

15 - Evidence Review Group report Erratum prepared by School of Health and Related Research (ScHARR)

16 - Manufacturer factual accuracy check of Evidence Review Group report 

17 – Journal article from European Urology

18 - Evidence Review Group response to query on PSA progression or death  

18 - Evidence Review Group additional analyses 

19 - Evidence Review Group corrections to the manufacturer’s economic model and incorporation of Committee’s preferred assumptions

 

* Users of Google chrome should click the link below and then click the small PDF icon in the far right of the address bar to successfully access this document *

 

This page was last updated: 20 December 2013